Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delobel

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
Journal for Immunotherapy of Cancer|August 23, 2024
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort studyLambert Assoumou, Raghiatou Baldé, Christine Katlama, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
AIDS (London, England)|September 20, 2017
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy eraCaroline Besson, Remi Lancar, Sophie Prevot, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
AIDS (London, England)|December 14, 2019
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIVCaroline Besson, Nicolas Noel, Remi Lancar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort StudyMarie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2024
Prosthetic Joint Infections due to Candida Species: A Multicenter International StudyAurélien Dinh, Martin McNally, Emma D'Anglejan, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
Journal for Immunotherapy of Cancer|August 23, 2024
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort studyLambert Assoumou, Raghiatou Baldé, Christine Katlama, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
AIDS (London, England)|September 20, 2017
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy eraCaroline Besson, Remi Lancar, Sophie Prevot, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
AIDS (London, England)|December 14, 2019
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIVCaroline Besson, Nicolas Noel, Remi Lancar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort StudyMarie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2024
Prosthetic Joint Infections due to Candida Species: A Multicenter International StudyAurélien Dinh, Martin McNally, Emma D'Anglejan, et al.
Pageof 16